SEC Form 4 Summary ROIV

Roivant Sciences director Daniel Allen Gold reports share sales

Roivant Sciences (ROIV) director Daniel Allen Gold sold 1,381,762 shares for $53,536,738.01 across seven transactions.

Transaction Value:
$53,536,738.01
Shares transacted:
1,381,762
Average price:
$38.75
Insider:

The Form 4 filing, a public report of an insider's stock activity, was filed on November 18, 2026. It covers sales from November 16 through November 17, 2026. Daniel Allen Gold is listed as a director of Roivant Sciences Ltd. (ROIV).

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-17
Buy/Sellsell
Transaction Count7
Shares Transacted1,381,762
Price$38.75
Total Transaction Value$53,536,738.01
Insider
Ticker SymbolROIV
CompanyRoivant Sciences Ltd.
Insider NameGold Daniel Allen
Insider TitleDirector
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction0
Position Size Change100.00%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

These were share sales, reported with transaction code S, which identifies a sale. The seven transactions appear in a single filing by one insider.

What was the average price of the transaction?

The average sale price was $38.75 per share, rounded to the nearest cent. This average covers the seven sales. Prices for each separate sale were not provided.

How did this transaction affect the insider's holdings?

The reported holding fell by 1,381,762 shares to zero. The sales covered 100.00% of the shares held in that balance before the trades. The available details do not show whether he had other holdings.

What's the total transaction value?

The seven sales had a total value of $53,536,738.01. This amount covers all the reported sales from November 16 through November 17, 2026.

Are there any special circumstances around this transaction?

The available transaction information did not identify a special arrangement. Filing footnote text was not provided, so further details about how the sales were arranged remain unknown. The available information also does not explain the reason for the sales.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.